
|Videos|January 29, 2018
What Was the Most Notable Orphan Drug Approval in 2017?
Joy Gilbert, Vice President, Operations, US Bioservices, a part of AmerisourceBergen, discusses the importance of new orphan drug approvals for patients.
Advertisement
Gilbert: Well, it’s interesting because there are many orphan drugs that have been approved and are in the pipeline, but for a patient who has an orphan or rare disease, whichever one is treating their disease is the most notable.
Many of these patients have not had treatment options before. So, the most important one is the one that is treating you, as the patient, or your family member.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
The Peptide Reclassification Everyone's Talking About: A Pharmacist's Take on What RFK Jr's Announcement Actually Means
2
What Pharmacists Need to Know About Retatrutide's TRIUMPH-1 Phase 3 Results
3
First-in-Human In Vivo CAR-T Therapy Shows Encouraging Activity in Relapsed/Refractory Multiple Myeloma
4
Apnimed Submits NDA for AD109 Following Positive Phase 3 Results in Obstructive Sleep Apnea
5




























































































































